Chimeric Therapeutics Limited (CHMMF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | - | 4.5 Million | 2.61 Million | - | - |
| Cost of Revenue | 3922.00 | 965.35 Thousand | 949.76 Thousand | 846.96 Thousand | - |
| Gross Profit | -3922.00 | 3.54 Million | 1.66 Million | -846.96 Thousand | - |
| Operating Expenses | 20.71 Million | 29.48 Million | 17.18 Million | 15.69 Million | 64 Thousand |
| Selling, General and Administrative Expenses | 9.56 Million | 11.92 Million | 9.13 Million | 6.16 Million | 64 Thousand |
| Research and Development Expenses | 11.14 Million | 13.47 Million | 5.17 Million | 3.77 Million | - |
| Other Expenses | - | 4.82 Million | 2.08 Million | -263.79 Thousand | - |
| Cost and Expenses | 20.71 Million | 29.48 Million | 17.18 Million | 15.69 Million | 64 Thousand |
| Operating Income | -20.71 Million | -24.63 Million | -15.09 Million | -15.1 Million | -64.01 Thousand |
| Interest Expense | 331.81 Thousand | 773.84 Thousand | 640.12 Thousand | 5877.00 | - |
| Income Tax Expense | -8.7 Million | 92.82 Thousand | 163.72 Thousand | -257.91 Thousand | -153.62 Thousand |
| Earnings before Tax | -21.23 Million | -25.4 Million | -15.73 Million | -15.11 Million | -64 Thousand |
| Net Income | -12.52 Million | -25.5 Million | -15.89 Million | -15.11 Million | -64 Thousand |
| Earnings Per Share Basic | -0.02 | -0.06 | -0.04 | -0.05 | -0.00 |
| Earnings Per Share Diluted | -0.02 | -0.06 | -0.04 | -0.05 | -0.00 |
| Weighted Average Shares Outstanding | 695.63 Million | 433.24 Million | 359.93 Million | 325.51 Million | 342.92 Million |
| Weighted Average Shares Outstanding (Diluted) | 695.63 Million | 433.24 Million | 359.93 Million | 325.5 Million | 342.92 Million |
| Gross Margin | - | 0.79 | 0.64 | - | - |
| EBIT Margin | - | -5.25 | -5.40 | - | - |
| Profit Margin | - | -5.66 | -6.07 | - | - |
| EBITDA | -20.71 Million | -23.66 Million | -14.14 Million | -14.26 Million | -64.01 Thousand |
| Earnings Before Tax Margin | - | -5.47 | -5.77 | - | - |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 5.48 Million | 5.48 Million | 4.5 Million | 705.81 Thousand |
| Cost of Revenue | 3922.00 | - | 486.77 Thousand | - | 965.35 Thousand | - |
| Gross Profit | -3922.00 | - | 4.99 Million | 5.48 Million | 3.54 Million | 705.81 Thousand |
| Operating Expenses | 20.71 Million | 16.77 Million | 8.72 Million | 4.15 Million | 29.48 Million | 14.82 Million |
| Selling, General and Administrative Expenses | - | 4.12 Million | 4.38 Million | 2.43 Million | - | 7.62 Million |
| Research and Development Expenses | - | 12.64 Million | 4.34 Million | 2.17 Million | - | 7.2 Million |
| Other Expenses | - | - | - | - | 4.82 Million | - |
| Cost and Expenses | 20.71 Million | 16.77 Million | 9.21 Million | 4.15 Million | 29.48 Million | 14.82 Million |
| Operating Income | -20.71 Million | -16.77 Million | -9.21 Million | 878.58 Thousand | -24.63 Million | -14.82 Million |
| Interest Expense | 331.81 Thousand | 80.00 | 331.73 Thousand | - | 773.84 Thousand | 763.54 Thousand |
| Income Tax Expense | -8.7 Million | -8.63 Million | -5.91 Million | 36.47 Thousand | 92.82 Thousand | -1.42 Million |
| Earnings before Tax | -21.23 Million | -23.6 Million | -3.47 Million | 1.18 Million | -25.4 Million | -15.59 Million |
| Net Income | -12.52 Million | -14.97 Million | 2.44 Million | 1.22 Million | -25.5 Million | -14.16 Million |
| Earnings Per Share Basic | - | -0.02 | 0.00 | 0.00 | - | -0.03 |
| Earnings Per Share Diluted | - | -0.02 | 0.00 | 0.00 | - | -0.03 |
| Weighted Average Shares Outstanding | 695.63 Million | 680.62 Million | 557.64 Million | 557.73 Million | 433.24 Million | 438.4 Million |
| Weighted Average Shares Outstanding (Diluted) | 695.63 Million | 680.62 Million | 557.64 Million | 557.64 Million | 433.24 Million | 438.4 Million |
| Gross Margin | - | - | 0.91 | 1.00 | 0.79 | 1.00 |
| EBIT Margin | - | - | -1.59 | 0.20 | - | -9.10 |
| Profit Margin | - | - | 0.45 | 0.22 | -5.66 | -20.08 |
| EBITDA | - | -16.77 Million | -8.72 Million | 1.12 Million | - | -6.42 Million |
| Earnings Before Tax Margin | - | - | -1.68 | 0.16 | -5.47 | -21.01 |
AMX
8742
IBE1
DBO
4432
9161